The Future of Medicine May Not Be Medication #shorts
4 Apr 2026 · 2 min

1:50
In this short interview, host McCall McPherson speaks with Dr. Carolyn Halpert of Columbia's BioXcellerator program about the rapidly evolving field of regenerative medicine. Dr. Halpert explains that regenerative medicine, a specialty only 15‑20 years old, leverages the body's innate healing capacity by using biological products such as platelet‑rich plasma (PRP), exosomes, secretomes, and stem cells. She describes the primary sources of stem cells—fat, bone marrow, and perinatal tissues—and notes that many patients in the United States, facing limited conventional treatment options, seek stem cell therapies abroad. The conversation highlights both the promise of these therapies and the current access gap within U.S. healthcare.










